JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Heat Emergency Awareness and Treatment (HEAT)

Not Applicable

Completed

Conditions: Heat Stroke
Heat Syncope, Sequela
Heat Illness
Heat Exhaustion
Heat Exposure
Heat Collapse
Heat
Heat Stroke and Sunstroke

Interventions: Behavioral: Regular Community Healthcare provision
Behavioral: Implementation of Community-based Home Heat Bundle

First Posted Date: 2018-05-01

Last Posted Date: 2019-01-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 16973

Registration Number: NCT03513315

Locations: 🇵🇰
Aga Khan University, Karachi, Pakistan
🇵🇰
The Aman Foundation, Karachi, Pakistan

Randomized Evaluation of Ten Allergy Skin Prick Test Devices

Not Applicable

Completed

Conditions: Allergic Rhinitis
Asthma
Food Allergy
Skin Testing

Interventions: Device: Histamine skin testing

First Posted Date: 2018-04-26

Last Posted Date: 2018-08-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT03509766

Locations: 🇺🇸
John Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States

A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients

Not Applicable

Completed

Conditions: Medication Adherence
Kidney Transplant

Interventions: Other: mHealth Intervention

First Posted Date: 2018-04-20

Last Posted Date: 2021-10-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT03504137

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Effect of Evolocumab on Coronary Endothelial Function

Phase 2

Completed

Conditions: Human Immunodeficiency Virus
Coronary Artery Disease

Interventions: Drug: Evolocumab

First Posted Date: 2018-04-18

Last Posted Date: 2020-07-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 19

Registration Number: NCT03500302

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Ketamine for Treatment of MS Fatigue

Phase 1

Completed

Conditions: Fatigue
Multiple Sclerosis

Interventions: Drug: Ketamine
Drug: Midazolam

First Posted Date: 2018-04-18

Last Posted Date: 2020-08-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 18

Registration Number: NCT03500289

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

Not Applicable

Completed

Conditions: Hiv

Interventions: Other: HIV D+/R+

First Posted Date: 2018-04-18

Last Posted Date: 2024-07-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 209

Registration Number: NCT03500315

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
UPMC-University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

and more 26 locations

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Not Applicable

Active, not recruiting

Conditions: Multiple Sclerosis, Relapsing-Remitting

Interventions: Other: Natalizumab, Alemtuzumab, Ocrelizumab, Rituximab, Cladribine, Ofatumumab, Ublituximab-xiiy
Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

First Posted Date: 2018-04-18

Last Posted Date: 2025-05-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 900

Registration Number: NCT03500328

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
The University of South Alabama, Mobile, Alabama, United States
🇺🇸
St. Joseph's Hospital & Medical Center - Barrow Neurological Institute, Phoenix, Arizona, United States

and more 44 locations

Nutritional Drink in Gastroparesis

Not Applicable

Withdrawn

Conditions: Gastroparesis

Interventions: Dietary Supplement: Nutrient drink

First Posted Date: 2018-04-18

Last Posted Date: 2023-03-13

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03500354

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

The Role of Skin Care Regimen in Skin Health

Not Applicable

Completed

Conditions: Itching
Xerosis

Interventions: Other: skin care regimen

First Posted Date: 2018-04-13

Last Posted Date: 2020-05-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 54

Registration Number: NCT03497130

Locations: 🇺🇸
Cutaneous Translational Research Program, Baltimore, Maryland, United States

Assessing the Safety of Buprenorphine in People With Sickle Cell Disease

Phase 2

Completed

Conditions: Sickle Cell Disease

Interventions: Drug: buprenorphine

First Posted Date: 2018-04-10

Last Posted Date: 2022-04-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 47

Registration Number: NCT03492099

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy